François Bricaire

TL;DR: In coinfected patients, a low CD4 count, alcohol consumption rate, and age at HCV infection are associated with a higher liver fibrosis progression rate, while HIV seropositivity accelerates HCV‐related liver Fibrosis progression.

TL;DR: None of the following variables were associated with an increased risk of lamivudine resistance: age, associated protease inhibitor therapy, Center for Disease Control (CDC) stage C, known HIV‐infection duration, serum HBV‐DNA level at baseline, CD4 cell count and serum alanine transaminase levels at baseline and atHBV‐replication suppression (2 months of lamvudine).

TL;DR: Evidence of a significantly reduced survival in patients with neurolisteriosis treated with adjunctive dexamethasone is found, and the time window for fetal losses is determined, which is higher than reported elsewhere.

TL;DR: Patients with travel-associated dermatosis are advised on how to avoid exposure to the agents and vectors of infectious dermatoses and travel first-aid kits should include insect repellents and antibiotics effective against bacterial skin infections.

TL;DR: An index including five biochemical markers accurately predicts significant fibrosis in patients with HIV/HCV co-infection, and may substantially reduce the necessity for liver biopsy.